|
1
|
Adams RR, Carmena M and Earnshaw WC:
Chromosomal passengers and the (aurora) ABCs of mitosis. Trends
Cell Biol. 11:49–54. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tatsuka M, Katayama H, Ota T, Tanaka T,
Odashima S, Suzuki F and Terada Y: Multinuclearity and increased
ploidy caused by overexpression of the Aurora B and Ipl1-like
midbody-associated protein mitotic kinase in human cancer cells.
Cancer Res. 58:4811–4816. 1998.PubMed/NCBI
|
|
3
|
Kurai M, Shiozawa T and Shih HC:
Expression of Aurora kinases A and B in normal, hyperplastic, and
malignant human endometrium: Aurora B as a predictor for poor
prognosis in endometrial carcinoma. Hum Pathol. 36:1281–1288. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lee EC, Frolov A, Li R, Ayala G and
Greenberg NM: Targeting Aurora kinases for the treatment of
prostate cancer. Cancer Res. 66:4996–5002. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sorrentino R, Libertini S, Pallante PL,
Troncone G, Palombini L, Bavetsias V, Spalletti-Cernia D, Laccetti
P, Linardopoulos S, Chieffi P, Fusco A and Portella G: Aurora B
overexpression associates with the thyroid carcinoma
undifferentiated phenotype and is required for thyroid carcinoma
cell proliferation. J Clin Endocrinol Metab. 90:928–935. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qi G, Ogawa I, Kudo Y, Miyauchi M,
Siriwardena BSMS, Shimamoto F, Tatsuka M and Takata T: Aurora-B
expression and its correlation with cell proliferation and
metastasis in oral cancer. Virchows Arch. 450:297–302. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ambrosini G, Adida C and Altieri DC: A
novel anti-apoptosis gene, Survivin, expressed in cancer and
lymphoma. Nat Med. 3:917–921. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chiou SK, Jones MK and Tarnawski AS:
Survivin an anti-apoptosis protein: its biological roles and
implications for cancer and beyond. Med Sci Monit. 9:125–129.
2003.PubMed/NCBI
|
|
9
|
Hsu JY, Sun ZW, Li X, Reuben M, Tatchell
K, Bishop DK, Grushcow JM, Brame CJ, Caldwell JA, Hunt DF, Lin R,
Smith MM and Allis CD: Mitotic phosphorylation of histone H3 is
governed by Ipl1/aurora kinase and Glc7/PP1 phosphatase in budding
yeast and nematodes. Cell. 102:279–291. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ota T, Suto S, Katayama H, Han ZB, Suzuki
F, Maeda M, Tanino M, Terada Y and Tatsuka M: Increased mitotic
phosphorylation of histone H3 attributable to AIM-1/Aurora B
overexpression contributes to chromosome number instability. Cancer
Res. 62:5168–5177. 2002.PubMed/NCBI
|
|
11
|
Kanda A, Kawai H, Suto S, Kitajima S, Sato
S, Takata T and Tatsuka M: Aurora-B/AIM-1 kinase activity is
involved in Ras-mediated cell transformation. Oncogene.
24:7266–7272. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Honda R, Korner R and Nigg EA: Exploring
the functional interactions between Aurora B, INCENP, and Survivin
in mitosis. Mol Biol Cell. 14:3325–3341. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Beardmore VA, Ahonen LJ, Gorbsky GJ and
Kallio MJ: Survivin dynamics increases at centromeres during G2/M
phase transition and is regulated by microtubule-attachment and
Aurora B kinase activity. J Cell Sci. 117:4033–4042. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Stauber RH, Mann W and Knauer SK: Nuclear
and cytoplasmic Survivin: Molecular mechanism, prognostic, and
therapeutic potential. Cancer Res. 67:5999–6002. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Knauer SK, Bier C, Habtemichael N and
Stauber RH: The Survivin-Crm1 interaction is essential for
chromosomal passenger complex localization and function. EMBO Rep.
7:1259–1265. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Colnaghi R, Connell CM, Barrett RM and
Wheatley SP: Separating the anti-apoptotic and mitotic roles of
survivin. J Biol Chem. 281:33450–33456. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tanaka K, Iwamoto S, Gon G, Nohara T,
Iwamoto M and Tanigawa N: Expression of Survivin and its
relationship to loss of apoptosis in breast carcinomas. Clin Cancer
Res. 6:127–134. 2000.PubMed/NCBI
|
|
18
|
Adida C, Haioun C, Gaulard P, et al:
Prognostic significance of Survivin expression in diffuse large
B-cell lymphomas. Blood. 96:1921–1925. 2000.PubMed/NCBI
|
|
19
|
Ikeguchi M, Ueta T, Yamane Y, Hirooka Y
and Kaibara N: Inducible nitric oxide synthase and Survivin
messenger RNA expression in hepatocellular carcinoma. Clin Cancer
Res. 8:3131–3136. 2002.PubMed/NCBI
|
|
20
|
Wakana Y, Kasuya K, Katayanagi S, et al:
Effect of surviving on cell proliferation and apoptosis in gastric
cancer. Oncol Rep. 9:1213–1218. 2002.PubMed/NCBI
|
|
21
|
Qi G, Tuncel H, Aoki E, Tanaka S, Oka S,
Kaneko I, Okamoto M, Tatsuka M, Nakai S and Shimamoto F:
Intracellular localization of survivin determines biological
behavior in colorectal cancer. Oncol Rep. 22:557–562.
2009.PubMed/NCBI
|
|
22
|
Qi G, Kudo Y, Ando T, Siriwardena BSMS,
Yoshida M, Keikahee MR, Ogawa I and Takata T: Nuclear Survivin
expression is correlated with malignant behaviors of head and neck
cancer together with Aurora-B. Oral Oncol. 46:263–270. 2010.
View Article : Google Scholar : PubMed/NCBI
|
